GSK vs TAOX · P/E 13, $103.31B cap vs rev $477.4K
GlaxoSmithKline PLC ADR (GSK) versus TAO Synergies Inc. (TAOX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
TAO Synergies Inc. (TAOX) is a software - infrastructure company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported TAOX revenue for 2026-06-30 was $477.4K. Net income was -$5.0M. Revenue was up 22.8% from 2026-03-31 to 2026-06-30. TAOX currently screens at market cap $30.2M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TAOX currently screens at market cap $30.2M.
Not investment advice. Open the GSK and TAOX stock pages for the full models.
Not investment advice.